Cargando…

Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion

BACKGROUND: We recently provided evidence that HIV-1 enters HeLa-derived TZM-bl and lymphoid CEMss cells by fusing with endosomes, whereas its fusion with the plasma membrane does not proceed beyond the lipid mixing step. The mechanism of restriction of HIV-1 fusion at the cell surface and/or the fa...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Vega, Michelle, Marin, Mariana, Kondo, Naoyuki, Miyauchi, Kosuke, Kim, Yuri, Epand, Raquel F, Epand, Richard M, Melikyan, Gregory B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297528/
https://www.ncbi.nlm.nih.gov/pubmed/22145853
http://dx.doi.org/10.1186/1742-4690-8-99
_version_ 1782225881341624320
author de la Vega, Michelle
Marin, Mariana
Kondo, Naoyuki
Miyauchi, Kosuke
Kim, Yuri
Epand, Raquel F
Epand, Richard M
Melikyan, Gregory B
author_facet de la Vega, Michelle
Marin, Mariana
Kondo, Naoyuki
Miyauchi, Kosuke
Kim, Yuri
Epand, Raquel F
Epand, Richard M
Melikyan, Gregory B
author_sort de la Vega, Michelle
collection PubMed
description BACKGROUND: We recently provided evidence that HIV-1 enters HeLa-derived TZM-bl and lymphoid CEMss cells by fusing with endosomes, whereas its fusion with the plasma membrane does not proceed beyond the lipid mixing step. The mechanism of restriction of HIV-1 fusion at the cell surface and/or the factors that aid the virus entry from endosomes remain unclear. RESULTS: We examined HIV-1 fusion with a panel of target cells lines and with primary CD4(+ )T cells. Kinetic measurements of fusion combined with time-resolved imaging of single viruses further reinforced the notion that HIV-1 enters the cells via endocytosis and fusion with endosomes. Furthermore, we attempted to deliberately redirect virus fusion to the plasma membrane, using two experimental strategies. First, the fusion reaction was synchronized by pre-incubating the viruses with cells at reduced temperature to allow CD4 and coreceptors engagement, but not the virus uptake or fusion. Subsequent shift to a physiological temperature triggered accelerated virus uptake followed by entry from endosomes, but did not permit fusion at the cell surface. Second, blocking HIV-1 endocytosis by a small-molecule dynamin inhibitor, dynasore, resulted in transfer of viral lipids to the plasma membrane without any detectable release of the viral content into the cytosol. We also found that a higher concentration of dynasore is required to block the HIV-endosome fusion compared to virus internalization. CONCLUSIONS: Our results further support the notion that HIV-1 enters disparate cell types through fusion with endosomes. The block of HIV-1 fusion with the plasma membrane at a post-lipid mixing stage shows that this membrane is not conducive to fusion pore formation and/or enlargement. The ability of dynasore to interfere with the virus-endosome fusion suggests that dynamin could be involved in two distinct steps of HIV-1 entry - endocytosis and fusion within intracellular compartments.
format Online
Article
Text
id pubmed-3297528
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32975282012-03-09 Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion de la Vega, Michelle Marin, Mariana Kondo, Naoyuki Miyauchi, Kosuke Kim, Yuri Epand, Raquel F Epand, Richard M Melikyan, Gregory B Retrovirology Research BACKGROUND: We recently provided evidence that HIV-1 enters HeLa-derived TZM-bl and lymphoid CEMss cells by fusing with endosomes, whereas its fusion with the plasma membrane does not proceed beyond the lipid mixing step. The mechanism of restriction of HIV-1 fusion at the cell surface and/or the factors that aid the virus entry from endosomes remain unclear. RESULTS: We examined HIV-1 fusion with a panel of target cells lines and with primary CD4(+ )T cells. Kinetic measurements of fusion combined with time-resolved imaging of single viruses further reinforced the notion that HIV-1 enters the cells via endocytosis and fusion with endosomes. Furthermore, we attempted to deliberately redirect virus fusion to the plasma membrane, using two experimental strategies. First, the fusion reaction was synchronized by pre-incubating the viruses with cells at reduced temperature to allow CD4 and coreceptors engagement, but not the virus uptake or fusion. Subsequent shift to a physiological temperature triggered accelerated virus uptake followed by entry from endosomes, but did not permit fusion at the cell surface. Second, blocking HIV-1 endocytosis by a small-molecule dynamin inhibitor, dynasore, resulted in transfer of viral lipids to the plasma membrane without any detectable release of the viral content into the cytosol. We also found that a higher concentration of dynasore is required to block the HIV-endosome fusion compared to virus internalization. CONCLUSIONS: Our results further support the notion that HIV-1 enters disparate cell types through fusion with endosomes. The block of HIV-1 fusion with the plasma membrane at a post-lipid mixing stage shows that this membrane is not conducive to fusion pore formation and/or enlargement. The ability of dynasore to interfere with the virus-endosome fusion suggests that dynamin could be involved in two distinct steps of HIV-1 entry - endocytosis and fusion within intracellular compartments. BioMed Central 2011-12-06 /pmc/articles/PMC3297528/ /pubmed/22145853 http://dx.doi.org/10.1186/1742-4690-8-99 Text en Copyright ©2011 de la Vega et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
de la Vega, Michelle
Marin, Mariana
Kondo, Naoyuki
Miyauchi, Kosuke
Kim, Yuri
Epand, Raquel F
Epand, Richard M
Melikyan, Gregory B
Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion
title Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion
title_full Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion
title_fullStr Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion
title_full_unstemmed Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion
title_short Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion
title_sort inhibition of hiv-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297528/
https://www.ncbi.nlm.nih.gov/pubmed/22145853
http://dx.doi.org/10.1186/1742-4690-8-99
work_keys_str_mv AT delavegamichelle inhibitionofhiv1endocytosisallowslipidmixingattheplasmamembranebutnotcompletefusion
AT marinmariana inhibitionofhiv1endocytosisallowslipidmixingattheplasmamembranebutnotcompletefusion
AT kondonaoyuki inhibitionofhiv1endocytosisallowslipidmixingattheplasmamembranebutnotcompletefusion
AT miyauchikosuke inhibitionofhiv1endocytosisallowslipidmixingattheplasmamembranebutnotcompletefusion
AT kimyuri inhibitionofhiv1endocytosisallowslipidmixingattheplasmamembranebutnotcompletefusion
AT epandraquelf inhibitionofhiv1endocytosisallowslipidmixingattheplasmamembranebutnotcompletefusion
AT epandrichardm inhibitionofhiv1endocytosisallowslipidmixingattheplasmamembranebutnotcompletefusion
AT melikyangregoryb inhibitionofhiv1endocytosisallowslipidmixingattheplasmamembranebutnotcompletefusion